Anti-CD40 also increased significantly AH1-specific TCR repertoire sharing between the tumor and draining lymph node (dLN) of each mouse as compared to controls (Fig. 7c), supporting the interpretation that the main effect of anti-CD40 is to increase cDC1 activation and tumor-specific T cell priming. Here, CD40 is linked to neoplasm.